9-603192-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015158.5(KANK1):​c.-83-73698T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.367 in 151,710 control chromosomes in the GnomAD database, including 12,636 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 12636 hom., cov: 32)

Consequence

KANK1
NM_015158.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.174

Publications

6 publications found
Variant links:
Genes affected
KANK1 (HGNC:19309): (KN motif and ankyrin repeat domains 1) The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
KANK1 Gene-Disease associations (from GenCC):
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 2
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.549 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015158.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
NM_015158.5
MANE Select
c.-83-73698T>G
intron
N/ANP_055973.2Q14678-1
KANK1
NM_001256876.3
c.-84+62525T>G
intron
N/ANP_001243805.1Q14678-1
KANK1
NM_001256877.3
c.-84+53471T>G
intron
N/ANP_001243806.1Q14678-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
ENST00000382297.7
TSL:1 MANE Select
c.-83-73698T>G
intron
N/AENSP00000371734.2Q14678-1
KANK1
ENST00000382303.5
TSL:1
c.-84+62525T>G
intron
N/AENSP00000371740.1Q14678-1
KANK1
ENST00000619269.5
TSL:5
c.-83-73698T>G
intron
N/AENSP00000477725.2A0A8J9BYE6

Frequencies

GnomAD3 genomes
AF:
0.368
AC:
55721
AN:
151596
Hom.:
12641
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.141
Gnomad AMI
AF:
0.377
Gnomad AMR
AF:
0.313
Gnomad ASJ
AF:
0.454
Gnomad EAS
AF:
0.100
Gnomad SAS
AF:
0.567
Gnomad FIN
AF:
0.454
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.504
Gnomad OTH
AF:
0.403
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.367
AC:
55701
AN:
151710
Hom.:
12636
Cov.:
32
AF XY:
0.367
AC XY:
27175
AN XY:
74144
show subpopulations
African (AFR)
AF:
0.140
AC:
5779
AN:
41154
American (AMR)
AF:
0.312
AC:
4768
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.454
AC:
1574
AN:
3470
East Asian (EAS)
AF:
0.0998
AC:
517
AN:
5180
South Asian (SAS)
AF:
0.566
AC:
2724
AN:
4810
European-Finnish (FIN)
AF:
0.454
AC:
4802
AN:
10566
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.504
AC:
34229
AN:
67966
Other (OTH)
AF:
0.397
AC:
832
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1573
3146
4718
6291
7864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.293
Hom.:
927
Bravo
AF:
0.340

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
11
DANN
Benign
0.78
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1532309; hg19: chr9-603192; API